Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 15051 - 15075 of 15448 in total

Carbuterol

Experimental

Quifenadine

Experimental

Aluminium clofibrate

Experimental

Xipamide

Experimental

2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine

Experimental

N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE

Experimental

6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one

Experimental

Dipipanone

Experimental
Illicit

Balanol Analog 2

Experimental

2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide

Experimental

Iodobenzene

Experimental

AL7182

Experimental

1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane

Experimental

4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid

Experimental

PAS219

Experimental

(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester

Experimental

FR239087

Experimental

Phenacetin

Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn

1,3,5-trichlorobenzene

Experimental

4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid

Experimental

1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea

Experimental

N-(Chlorophenyl)-N'-hydroxyguanidine

Experimental

(R)-4-Nitrostyrene oxide

Experimental

Cannabinor

Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational

Indisulam

Investigational
Displaying drugs 15051 - 15075 of 15448 in total